Literature DB >> 1733956

A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine.

A Wellstein1, W J Fang, A Khatri, Y Lu, S S Swain, R B Dickson, J Sasse, A T Riegel, M E Lippman.   

Abstract

We report purification of an 18-kDa heparin-binding growth factor secreted from human cancer cells which is homologous to a developmentally regulated, neurotrophic factor, heparin-binding growth-associated molecule/pleiotrophin (HB-GAM/PTN; Merenmies, J., and Rauvala, H. (1990) J. Biol. Chem. 265, 16721-16724; Li, Y. S., Milner, P. G., Chauhan, A. K., Watson, M. A., Hoffman, R. M., Kodner, C. M., Milbrandt, J., and Deuel, T. F. (1990) Science 250, 1690-1694). We have purified the protein from tissue culture supernatants of human breast cancer cells (MDA-MB 231) and have used soft agar cloning of an epithelial cell line (SW-13) to detect its growth stimulating activity. A 32,000-fold purification was achieved by isoelectric focusing, heparin affinity chromatography, and reversed phase high pressure liquid chromatography. The molecular mass of the protein was confirmed by gel filtration chromatography in the presence of detergent and bioassay of the fractions. The N-terminal sequence was homologous to HB-GAM/PTN, and polymerase chain reaction amplification and DNA sequencing confirmed that the respective transcript was present in the cancer cells. We conclude that HB-GAM/PTN can function as a tumor growth factor in addition to its role during neuronal development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733956

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta.

Authors:  K Meng; A Rodriguez-Peña; T Dimitrov; W Chen; M Yamin; M Noda; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Selective thrombosis of tumor blood vessels in mammary adenocarcinoma implants in rats.

Authors:  M K Samoszuk; M Y Su; A Najafi; O Nalcioglu
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.

Authors:  D C Stylianou; A Auf der Maur; D P Kodack; R T Henke; S Hohn; J A Toretsky; A T Riegel; A Wellstein
Journal:  Oncogene       Date:  2009-07-27       Impact factor: 9.867

4.  Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma.

Authors:  Elizabeth Y Qin; Dominique D Cooper; Keene L Abbott; James Lennon; Surya Nagaraja; Alan Mackay; Chris Jones; Hannes Vogel; Peter K Jackson; Michelle Monje
Journal:  Cell       Date:  2017-08-17       Impact factor: 41.582

5.  Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus.

Authors:  A M Schulte; S Lai; A Kurtz; F Czubayko; A T Riegel; A Wellstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis.

Authors:  T Taki; T Ohnishi; N Arita; S Hiraga; Y Saitoh; S Izumoto; K Mori; T Hayakawa
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin.

Authors:  A M Schulte; A Wellstein
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 8.  The role of pleiotrophin and beta-catenin in fetal lung development.

Authors:  Tingting Weng; Lin Liu
Journal:  Respir Res       Date:  2010-06-18

Review 9.  Anti-invasion drugs.

Authors:  R B Dickson; M D Johnson; M Maemura; J Low
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 10.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.